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Background: Representative statistics of surgical care among patients with kidney cancer are scant. With the
introduction of the diagnosis related group system in Germany, it is now possible to provide nationwide statistics
on surgical care. We studied in-hospital mortality risk in relation to comorbidity and complications, length of hospital stay
in relation to surgical approach and comorbidity, and risk of complications in relation to surgical approach among kidney
cancer patients undergoing nephrectomy.
Methods:We analyzed the nationwide hospitalization file of the years 2005 and 2006 including 23,753 hospitalizations
with a diagnosis of renal cancer and partial or complete nephrectomy and classified comorbidity (Charlson comorbidity
index) and complications. Length of stay, risk of in-hospital complications and in-hospital death were analyzed by linear
regression and log-linear regression (relative risks (RR) and 95% confidence intervals (95% CI)).
Results: The overall in-hospital mortality was 1.4%. Per one unit increase of the Charlson comorbidity index, the adjusted
risk of in-hospital mortality increased by 53% (95% CI 47-59%). The risks of bleeding or acute posthaemorrhagic anemia,
respiratory, urological and gastrointestinal complications and infections ranged between 1.1% and 2.7% with the
exception of bleeding or acute posthaemorrhagic anemia with 18.4%. Complications were associated with an
increased adjusted in-hospital mortality risk. Highest adjusted mortality risk ratios were observed for gastrointestinal
(RR = 3.61, 95% CI 2.32-5.63) and urological complications (RR = 3.62, 95% CI 2.62-5.00). The risk of haemorrhage or acute
posthaemorrhagic anemia was lower for total laparoscopic nephrectomies than total open nephrectomies. The adjusted
risk of gastrointestinal complications was lower for partial open compared to total open nephrectomy (adjusted RR = 0.66,
95% CI 0.45-0.97). Total laparoscopic nephrectomy was associated with shorter length of stay (−3.3 days; 95% CI
2.9-3.7 days) compared to total open nephrectomy. The estimated age-adjusted increase of length of stay per
one unit increase of the Charlson comorbidity index was 1.3 days (95% CI 1.2-1.4 days).
Conclusions: In this representative population-based analysis, we found that the surgical approach is associated
with the risk of complications and length of hospital stay. Furthermore, in the era of ageing populations, renal
cancer patients with comorbidities should be counseled about their increased in-hospital mortality risk.
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The estimated number of newly diagnosed patients with
renal cancer and deaths due to renal cancer is 115,200
cases and 49,000 cases in Europe in 2012, respectively.
Renal cancer accounts for 3.3% of all newly diagnosed
cancers in Europe (without non-melanoma skin cancer)
[1]. Surgical excision is the primary treatment [2]. Since
2006, laparoscopic radical nephrectomy has become an
established standard for the surgical treatment of renal
cancer [3]. According to the European guidelines,
nephron-sparing surgery (partial nephrectomy), is rec-
ommended for T1 tumors (≤7 cm diameter) and is an
option for T2 tumors [4]. Alternative treatment op-
tions include several percutaneous or open ablation
approaches. However, the recommended indications
for these approaches are small [4].
In 2002, Martin et al. developed 10 criteria for the
reporting of surgical outcomes [5]. Its limitation in-
cluded the lack of procedure-related variables. In 2007,
procedure-related complications of nephrectomy have
been added [6]. Typical complications after partial or total
nephrectomy include pneumothorax, haemorrhage and
acute posthaemorrhagic anemia, acute renal failure or in-
sufficiency, postoperative infection including peritonitis and
wound infection, and intestinal obstruction [7,8].
Our purpose was to describe the nationwide surgical
management of renal cancer in Germany and its patient
risk-factors and comorbidities adjusted association with
length of stay, complications and in-hospital mortality.
Methods
In 2004, the DRG (diagnosis related group) reimbursement
system became compulsory for hospitals. All hospitals that
are recompensated by the DRG-system annually transfer
their individual hospitalisation data to the DRG data center
(InEK). Hospitals have a strong incentive to report their
complete hospitalisation data. The German DRG statistics
is virtually a complete collection of hospitalizations all over
Germany with a few exceptions. The DRG data center
undertakes plausibility checks of the data and generates a
plausibility protocol that is sent back to the hospitals. Hos-
pitals can re-submit their corrected data files. Thereafter,
the DRG data center forwards anonymised data to the
Federal Bureau of Statistics. We were able to use the
hospitalization years 2005 and 2006 including overall 36.3
million hospitalizations.
The Federal Law on Statistics (Bundesstatistikgesetz,
BstatG) allows the use of DRG hospitalization data for
scientific purposes (§ 16, (6), (7)) without ethical review.
These data are not publicly available but can be accessed
after permission. We received permission from the Federal
Bureau of Statistics to access this data.
For each hospitalization, one main diagnosis and up to
99 secondary diagnoses coded can be documented. In2005, diagnoses were coded according to the ICD-10-
GM version of 2005 [9]. In 2006, the ICD-10-GM ver-
sion 2006 was used [10]. The diagnosis that led to the
hospitalization assessed at the end of the hospitalization
is defined as the main diagnosis. Up to 100 medical pro-
cedures can be coded according to German classification
of operations and procedures (OPS), a classification that
represents a German version of the International Classi-
fication of Procedures in Medicine (ICPM). In 2005 and
2006, the OPS versions of the years 2005 and 2006 re-
spectively were used [11,12].
We retrieved all hospitalizations that included a main
diagnosis of renal cancer (ICD-10: C64) and a procedure
code for partial, simple, radical and other types of neph-
rectomy (Additional file 1: Table S1). For the analysis,
we only distinguished between partial and total (simple
or radical) nephrectomy.
We excluded hospitalizations when 1) renal cancer
was only a secondary diagnosis, 2) renal cancer (primary
diagnosis) and pelvis cancer (secondary diagnosis) were
simultaneously coded, 3) the coding of the surgical ap-
proach was ambiguous, or 4) age, gender or places of
residence were missing. Based on the type and surgical
approach we categorized nephrectomies as total open,
total laparoscopic, partial nephrectomies. A small pro-
portion of nephrectomies had unspecific, unclear or
implausible coding (Additional file 1: Table S2).
We used a coding algorithm for defining comorbidities
in ICD-10 administrative databases [13] to derive the
Charlson comorbidity index (CCI) [14]. The German
hospitalization file contains up to 100 ICD-10 coded diag-
noses. We used these codes to derive the CCI that con-
tains overall 17 chronic diseases with different weighting
factors (Additional file 1: Table S3). As all included pa-
tients had a renal cancer diagnosis, we removed this item
from the calculation of the CCI.
We used an adaption of an established algorithm to
derive procedure-related in-hospital complications after
nephrectomy [8]. For bleeding, we also derived proced-
ure codes that allowed the identification of bleedings
that required blood transfusion (Additional file 1: Table
S4). We also extracted age at hospital admission, gender,
length of hospital stay in days (LOS) and in-hospital
mortality.
Statistical methods
The unit of analysis was the hospital admission with a
diagnosis of renal cancer and a partial or total nephrec-
tomy. We excluded 199 and 209 hospitalizations because
surgical coding was arbitrary and demographic data (age,
gender, place of residence) was missing respectively. The
final data set included 23,753 hospitalizations. For the
study of the association between type of nephrectomy
and LOS, we used a linear regression with LOS as the
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to estimate relative risks (RR) and 95% confidence inter-
vals (95% CI) for the association between type of surgery
(reference group: total open nephrectomy) and dichot-
omous outcomes like bleeding, bleeding requiring blood
transfusion, and in-hospital mortality. We checked the
model assumptions by visual inspection of residual plots.
Model assumptions were fulfilled. As age and comorbidity
are confounders of these associations, we adjusted our
analyses for both variables.
Results
From 2005 through 2006, the overall number of 23,753
nephrectomies included 10.6% renal cancers that either
had lymph node or distant metastasis. The median LOS
was 11 days and the in-hospital mortality was 1.4%. The
sex-specific comparison revealed that women were one
year older than men, their median LOS was one day lon-
ger than for men, and their median Charlson comorbid-
ity score was zero as opposed to one among men. The
probability of partial nephrectomy was lower among
women than men (RR = 0.79, 95% CI 0.75-0.83, adjusted
for age and Charlson comorbidity index). An age-
stratified analysis revealed that this sex difference was
restricted to women aged 60 years or more (<60 years:
RR = 0.97, 95% CI 0.87-1.07; ≥ 60 years: RR = 0.73, 95%
CI 0.68-0.78). Overall 17.9% of all nephrectomies were per-
formed as partial nephrectomies. The proportion of laparo-
scopically partial and total nephrectomies was 0.9% and
7.6% respectively. The most frequent type of nephrectomy
was total open nephrectomy (71.6%) (Table 1).
Risks of gastrointestinal (mainly postoperative intes-
tinal ileus) and respiratory (mainly acute respiratory or
pulmonary insufficiency and pneumothorax) complica-
tions were 1.1% and 2.7% respectively. The risk of haem-
orrhage or an acute posthaemorraghic anemia was
18.4%. Haemorrhages were coded in 4.5% of all patients.
The risk of haemorrhage or an acute posthaemorraghic
anemia that required blood transfusion was 13.5%. The
risk of urological complications was 2.3% and was
mainly due to acute renal failure (in 521 out of 546 pa-
tients (95.4%)). The risk of infections was 1.9% (Table 1
& Additional file 1: Table S4). Whereas haemodialysis
was performed among 1.7% (383/23,207) of patients with-
out urological complications, this proportion was 27.7%
(151/546) among patients with urological complications.
LOS was associated with the type of nephrectomy and
complications after nephrectomy. In comparison to total
open nephrectomy, total laparoscopic nephrectomy was
associated with about −3.3 days shorter hospital stays
after adjustment for age and comorbidities. Partial neph-
rectomy was only weakly associated with a shorter hos-
pital stay (−0.8 days) (Additional file 1: Table S5). After
adjustment for age, comorbidity, and type of surgery, allcomplications after nephrectomy were associated with a
considerable prolongation of the estimated LOS. Infections
(+12.8 days) and urological complications (+9.7 days)
were associated with the longest prolongation of LOS
(Additional file 1: Table S6).
The adjusted RR of gastrointestinal complications was
lower for partial nephrectomy than total open nephrec-
tomy (RR = 0.66, 95% CI 0.45-0.97). Furthermore, the
adjusted RR of haemorrhage or acute posthaemorrhagic
anemia was lower for total laparoscopic nephrectomy
compared to total open nephrectomy (RR = 0.69, 95% CI
0.61-0.78). A restriction to those haemorrhages or acute
posthaemorrahagic anemias that resulted in blood trans-
fusion revealed an even lower risk for total laparoscopic
nephrectomy compared to total open nephrectomy. The
adjusted RR of urologic complications was increased for
partial open nephrectomies compared to total open
nephrectomy (RR = 1.45, 95% CI 1.18-1.78) (Table 2).
Charlson comorbidity index was positively associated
with the LOS and risk of in-hospital death. Whereas pa-
tients with an index of zero had a median LOS of
11 days, patients with an index of seven or more had a
median LOS of 19 days. The estimated age-adjusted in-
crease of LOS per one unit increase of the Charlson co-
morbidity index was 1.3 days (95% CI 1.2-1.4 days). Per
one unit increase of the index, the adjusted risk of in-
hospital death increased by 53% (95% CI 47-59%)
(Table 3). Overall 19.1%, 2.9%, 0.4%, and 0.07% of all
nephrectomies were associated with one, two, three and
four or more complications respectively. For subjects
with no complications, the risk of in-hospital death was
0.6%. All complications were associated with increased
adjusted RRs of in-hospital death. We observed the
highest adjusted RR of in-hospital mortality for gastro-
intestinal (RR = 3.61) and urologic complications (RR =
3.62) (Table 4).
Partial and laparoscopic nephrectomy was associated
with a lower in-hospital mortality (adjusted RR = 0.39,
95% CI 0.25-0.62 and adjusted RR = 0.34, 95% CI 0.17-
0.67, respectively). Patients with lymph node or distant
metastases had higher mortality risks compared to pa-
tients with localized disease (adjusted RR = 1.63, 95% CI
1.12-2.38 and adjusted RR = 4.13, 95% CI 3.21-5.31,
respectively).
Discussion
Overall 17.9% of all nephrectomies were performed as
partial nephrectomies. The age and comorbidity adjusted
LOS was shorter for total laparoscopic nephrectomy
than total open nephrectomy. The adjusted risk of
bleeding or acute posthaemorraghic anemia was also
lower for total laparoscopic nephrectomies compared to
total open nephrectomies. Typical procedure-associated
risks ranged between 1.1% and 2.7% with the exception
Table 1 Characteristics of patients undergoing nephrectomy for the treatment of renal cancer in Germany, 2005-2006
All Men Women
Hospitalizations 23,753 14,823 8,930
Lymph node (Ndl) and distant metastasis status
Ndl -, distant metastasis - 89.4 89.0 90.0
Ndl +, distant metastasis - 1.7 1.7 1.7
Ndl +, distant metastasis + 1.7 1.9 1.4
Ndl -, distant metastasis + 7.2 7.4 6.9
Age (years) at hospitalization (%)
< 40 2.9 2.8 3.1
40-49 8.0 8.6 6.8
50-59 17.7 19.6 14.5
60-69 33.4 35.0 30.9
70-79 30.2 28.5 33.1
≥ 80 7.8 5.5 11.5
Median age (P10-P90) 66 (49–78) 66 (48–77) 68 (50–80)
Length of hospital stay (days) Median (P10-P90) 11 (8–20) 11 (8–20) 12 (8–21)
Intrahospital mortality (%) 1.4 1.5 1.3
Charlson comorbidity index: Median (P10-P90) 1.0 (0–4) 1.0 (0–4) 0 (0–3)
Type and surgical approach (%)
Partial (any) 17.9 19.4 15.3
Partial, open 17.0 18.4 14.7
Partial, laparoscopic 0.9 1.0 0.6
Total (any) 79.2 77.6 81.9
Total, open 71.6 70.1 74.3
Total laparoscopic 7.6 7.5 7.7
Unclear or implausible1) 2.9 3.0 2.7
Complications (%)
Gastrointestinal tract 1.1 1.2 1.0
Respiratory system 2.7 2.8 2.5
Bleeding or acute posthaemorrhagic anemia 18.4 17.8 19.4
Bleeding or acute posthaemorrhagic anemia
requiring blood transfusion
13.5 12.6 14.8
Urological system 2.3 2.6 1.7
Infections 1.9 2.0 1.8
Legend.
P10 and P90: 10th and 90th percentile; 1) Implausible combinations of codes like partial and simple nephrectomy or partial and radical nephrectomy;
the corresponding codes for the type of nephrectomy, surgical approach, complications, and Charlson comorbidity index are presented in the supplementary
online document.
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18.4%. All complications were associated with an in-
creased LOS, especially infections and urologic compli-
cations. Furthermore, all complications were associated
with increased risks of in-hospital deaths. Charlson co-
morbidity index was strongly associated with the LOS
and risk of in-hospital death.
The proportion of partial nephrectomy for the treat-
ment of renal cancer was 31% in Italy in 2007 [15] and45.2% in the United States in 2006 [16]. A high propor-
tion of partial nephrectomy probably reflects increased
surgeon education and greater surgeon comfort with
partial nephrectomy [16]. In our study, this proportion
was considerably lower (17.9%) and may be due to the
inclusion of renal cancer patients of any age and stage as
compared to e.g. the USA that only included renal can-
cer patients aged 40–90 years with a maximum tumor
diameter of 4 cm. Alternatively, the lack of incentives
Table 2 Surgical approaches of nephrectomy, crude risks of in-hospital complications and adjusted relative risks of
complications in Germany 2005-2006
Partial nephrectomy Total nephrectomy Adjusted relative risks of
complications in comparison to
total open nephrectomy
Open Lap. Partial Total Lap.
Subjects (N) 4,244 17,017 1,797 RR 95% CI RR 95% CI
Complications (%)
Gastrointestinal 0.7 1.2 1.6 0.66 0.45-0.97 1.46 0.98-2.16
Respiratory 2.8 2.7 1.8 1.11 0.91-1.36 0.75 0.53-1.06
Bleeding or acute posthaemorrhage anemia 18.5 19.0 11.9 1.08 1.01-1.16 0.69 0.61-0.78
Bleeding or acute posthaemorrhage anemia
requiring blood transfusion
12.1 14.4 7.2 0.96 0.88-1.05 0.57 0.48-0.67
Urologic 2.7 2.3 1.3 1.40 1.14-1.72 0.68 0.45-1.03
Infection 1.9 1.9 1.7 1.08 0.85-1.38 0.97 0.67-1.39
Legend.
Unclear nephrectomies (N = 695, 2.9%) not shown; Lap.: laparoscopic; relative risks are adjusted for age and Charlson comorbidity index; 95% CI: 95%
confidence interval.
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this finding as reimbursement is identical for open and
laparoscopic nephrectomy. A potential disadvantage of par-
tial nephrectomy is the risk of local recurrence estimated to
be 3-6% [2] and its technical demand [17]. Similarly as in
the US, we found that men had a higher probability under-
going partial nephrectomy than women [18].
Despite some standardization approaches of surgical
complication reporting [5,6], definitions of surgical compli-
cations are frequently not reported and lack a consensus
among urologists [6] resulting in risks of complications
from 2% to 54% [19,20]. Bleeding can be distinguished into
three forms: acute, postoperative, and delayed occurrence
of bleeding [3]. Roos et al. used the percentage ofTable 3 Charlson comorbidity index, median length of hospita
relative risks of death in Germany, 2005-2006
Length of hospital stay Obse
Charlson N % Median P10-P90
0 11,687 49.2 11 8-16
1 3,632 15.3 11 8-19
2 3,234 13.6 12 8-22
3 2,726 11.5 13 9-26
4 1,111 4.7 14 9-29
5 782 3.3 15 9-32
6 356 1.5 15 9-35
≥ 7 225 0.9 19 10-42
Per 1 unit increment
Legend.
Percentages are row percentages, that is, percent of deaths within levels of Charlso
95% CI: 95%% confidence interval; per 1 unit increment: estimated relative risk per
adjustment for age (continuous).patients who received a blood transfusion as a surro-
gate of perioperative bleeding and found that this propor-
tion ranges between 6.8% and 18.0% [21]. If we used this
definition, the risk of perioperative bleeding in Germany
would be 19.1%. However, the coding of bleeding plus
blood transfusion occurred in only 4.5%. This risk is in
line with previous tertiary center studies [8,22]. When we
also used codes that indicated the acute consequence of
bleeding (acute postoperative haemorrhagic anemia), this
risk increased to 18.4%. Kim et al. defined bleeding as the
occurrence of haemorrhage or acute post haemorrhagic
anemia and observed a rate of 8.5%, 5.3%, and 7.0% for
open radical, laparoscopic radical, and open partial neph-
rectomy respectively [23]. These rates are still considerablyl stay, observed in-hospital deaths and estimated adjusted
Relative risk of in-hospital death
rved in-hospital deaths Crude analysis Adjusted analysis
N % RR 95% CI RR 95% CI
38 0.3
38 1.1 2.41 1.59-3.66 2.4 1.33-3.13
39 1.2 2.78 1.84-4.21 2.47 1.62-3.76
84 3.1 7.10 5.03-10.03 6.35 4.45-9.05
38 3.4 7.88 5.20-11.94 6.12 3.97-9.43
40 5.1 11.79 7.84-17.72 9.91 6.53-15.05
29 8.2 18.78 12.05-29.25 14.43 9.11-22.85
31 13.8 26.43 15.81-44.17 18.88 10.98-32.47
1.58 1.52-1.65 1.53 1.47-1.59
n comorbidity indices; P10 and P90: 10th and 90th percentile; RR: relative risk;
1 unit increase of the Charlson comorbidity index; IQR: interquartile range;
Table 4 Association between complications after partial or total nephrectomy and risk of in-hospital death in Germany,
2005-2006
Frequency of complication In-hospital deaths Relative risk of
in-hospital death
N % N % Adj. RR 95% CI
No complication 18,415 77.5 108 0.6
Complication
Gastrointestinal 263 1.1 18 6.8 3.61 2.32-5.63
Respiratory 636 2.7 44 6.9 2.05 1.30-3.03
Urologic 546 2.3 102 18.7 3.62 2.62-5.00
Infection 449 1.9 18 4.0 2.45 1.47-4.07
Bleeding or acute posthaemorrhage anemia 4,371 18.4 188 4.3 2.11 1.73-2.57
Bleeding or acute posthaemorrhage anemia requiring blood transfusion 3,086 13.0 157 5.1 1.96 1.57-2.44
Legend.
Overall 23,753 hospitalizations included; for each complication, the reference group consists of hospitalizations without the corresponding complication;
all relative risks are adjusted for age and Charlson comorbidity index.
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the higher rates in Germany: first, in contrast to studies
based on the National Inpatient Sample of the USA, we
used all 100 ICD-10 codes to identify haemorrhage and
acute post haemorrhagic anemia; second, recording of
complications is triggered by reimbursement incentives
[24] that may differ between the USA and Germany.
The estimated average volume of intraoperative blood
loss during partial laparoscopic nephrectomy is 150–250
ccm [25]. Among 200 patients undergoing partial lap-
aroscopic nephrectomy, overall 3.5% suffered from intra-
operative haemorrhage. However, among these patients
the mean blood loss was 1,425 ccm [26]. As others [21],
we found that the median LOS was shorter and the risk
of haemorrhage or acute postoperative haemorrhagic
anemia that required blood transfusion was lower among
patients undergoing total laparoscopic nephrectomy com-
pared to total open nephrectomy. However, our study and
many case series of nephrectomy may suffer from a selec-
tion effect also called confounding by indication: renal can-
cer treated by laparoscopic nephrectomy tends to have a
lower stage at diagnosis [16]. The only staging information
available in our data set was related to the presence of
lymph node and distant metastases. Patients with lymph
node or distant metastases were less likely to undergo lap-
aroscopic nephrectomy than patients without metastases.
Confounding by indication may also have influenced the
association between type of nephrectomy (laparoscopic
or partial, respectively) and in-hospital mortality in our
analyses.
The adjusted relative risk of gastrointestinal complica-
tions (mainly postoperative intestinal ileus) was lower
for partial nephrectomy compared to total open neph-
rectomy. Furthermore, the adjusted RR of postoperative
intestinal ileus was higher among patients undergoingtotal laparoscopic nephrectomy as compared to total open
nephrectomy. The higher adjusted RR of urologic compli-
cations (mainly renal failure) for partial nephrectomy may
reflect a selection bias towards patients with either a single
kidney or patients with chronic renal failure.
The adjusted increase of the LOS was largest for pa-
tients who acquired infections and renal failure. Renal
failure after partial nephrectomy results from a combin-
ation of intraoperative ischemia and loss of functioning
renal parenchyma. Chronic kidney disease is more com-
mon after radical nephrectomy than after partial neph-
rectomy, even in the presence of a normal contralateral
kidney and a normal preoperative concentration of cre-
atinine [27]. The degree of renal insufficiency is usually
mild and can be treated with adequate transfusion and
electrolyte management [28]. However, the considerably
higher proportion of patients requiring haemodialysis as-
sociated with the occurrence of urologic complications
(27.7%) compared to patients without this complication
(1.7%) in our study indicates that acute urologic compli-
cations are serious complications.
Similar as in other studies, the perioperative mortality
was very low [7,21,23]. The strong association between
comorbidity and in-hospital mortality has several impli-
cations: first, renal cancer patients with comorbidities
should be counseled about the mortality increase [29];
second, due to the ageing of Western industrialized pop-
ulations and therefore increase of comorbidity among
renal cancer patients, surgeons have to be aware of the
comorbidity-associated risk of complications and in-
hospital death; third, the quality of documentation and
coding of comorbidities obviously has some validity as
the expected well-known association between comor-
bidity and in-hospital mortality [19] could be replicated
based on these nationwide hospitalization data.
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previous population-based studies of the surgical man-
agement of renal cancer, we included all types of neph-
rectomies including laparoscopy and all stages of renal
cancer including metastasized cancer. It presents virtually a
nationwide, unbiased overview of all types of tumor neph-
rectomies undertaken in Germany and provides the most
comprehensive and contemporary analysis of the use of
nephrectomy for renal cancer treatment. Furthermore, we
used all available comorbidity diagnoses (up to 100 ICD-10
codes) whereas previous studies used 3 [30], 6 [15], 15 [8],
or up to 20 [7] diagnoses only to derive Charlson comor-
bidity index and complications.
However, there are inherent limitations of using ad-
ministrative data in clinical research [24]. First, for the
prediction of postoperative morbidity and mortality, sev-
eral factors beyond the Charlson comorbidity index, type
of nephrectomy and warm ischemia time play a role like
tumor T-stage, location and grade, obesity, anesthetic
techniques, surgeon experience and training, duration of
surgery or anesthesia, availability of equipment and
level of postoperative care [21,27]. Second, administra-
tive hospitalization data lack information on severity
(grade) of complications and therefore the Clavien
classification of surgical complications [19] cannot be
applied. We also could not estimate the reoperation
risk for bleeding after nephrectomy. Case series ana-
lyses have shown reoperation rates for bleeding of 1.5%
[22] and 2.2% [31]. Finally, our results are derived from
2005–2006 and management of kidney cancer may have
changed in favor of laparoscopic nephrectomy.
Conclusions
The nationwide analysis of tumor-related nephrectomies
shows a low proportion of partial nephrectomies that
may be due to the inclusion of all stages of renal cancers
or a lack of reimbursement incentives. In the era of age-
ing populations, renal cancer patients with comorbidities
should be counseled about their increased in-hospital
mortality risk. Administrative hospitalization data can
contribute to routine reporting of age- and comorbidity-
adjusted complication and in-hospital mortality rates.Additional file
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